Cetera Investment Advisers
EDIT icon

Cetera Investment Advisers’s Editas Medicine EDIT Stock Holding History

Cetera Investment Advisers’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.7K Sell
15,674
-414
-3% -$876 ﹤0.01% 4610
2025
Q4 		$33K Hold
16,088
– – ﹤0.01% 4548
2025
Q3 		$55.8K Buy
+16,088
New +$44.9K ﹤0.01% 4417
2021
Q4 		– Sell
-7,185
Closed -$295K – 1879
2021
Q3 		$295K Buy
7,185
+1,226
+21% +$67.2K ﹤0.01% 1450
2021
Q2 		$338K Buy
5,959
+1,183
+25% +$43.7K 0.01% 1342
2021
Q1 		$201K Sell
4,776
-1,577
-25% -$89.8K ﹤0.01% 1484
2020
Q4 		$445K Buy
+6,353
New +$261K 0.01% 1014

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return